Mental illness and use of screening mammography among medicaid beneficiaries

American Journal of Preventive Medicine

Volumn 42, Issue 6, 2012, Pages 606-609

  Koroukian, Siran M ^a,b   Bakaki, Paul M ^a   Golchin, Negar ^a   Tyler, Carl ^b   Loue, Sana ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEALTH CARE DISPARITY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAID; MENTAL DISEASE; VULNERABLE POPULATION;

BREAST NEOPLASMS; FEMALE; HUMANS; INSURANCE CLAIM REVIEW; MAMMOGRAPHY; MASS SCREENING; MEDICAID; MENTAL DISORDERS; MIDDLE AGED; OHIO; UNITED STATES;

EID: 84861148703     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2012.03.002     Document Type: Article

References (18)

1. C.J. Bushe, M. Taylor, J. Haukka Mortality in schizophrenia: a measurable clinical endpoint J Psychopharmacol 24 4S 2010 17 25
2. E. Tran, F. Rouillon, J.Y. Loze Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study Cancer 115 15 2009 3555 3562
3. D. Lawrence, S. Kisely, J. Pais The epidemiology of excess mortality in people with mental illness Can J Psychiatry 55 12 2010 752 760
4. S. Kisely, M. Smith, D. Lawrence, S. Maaten Mortality in individuals who have had psychiatric treatment: population-based study in Nova Scotia Br J Psychiatry 187 2005 552 558
5. S. Saha, D. Chant, J. McGrath A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64 10 2007 1123 1131
6. C.K. Chang, R.D. Hayes, M. Broadbent All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study BMC Psychiatry 10 2010 77
7. P. Auquier, C. Lancon, F. Rouillon, M. Lader, C. Holmes Mortality in schizophrenia Pharmacoepidemiol Drug Saf 15 12 2006 873 879
8. C.H. Hennekens, A.R. Hennekens, D. Hollar, D.E. Casey Schizophrenia and increased risks of cardiovascular disease Am Heart J 150 6 2005 1115 1121
9. M. De Hert, J.M. Dekker, D. Wood, K.G. Kahl, R.I. Holt, H.J. Moller Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) Eur Psychiatry 24 6 2009 412 424
10. L.F. Van Gaal Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity Eur Neuropsychopharmacol 16 S3 2006 S142 S148
11. B.G. Druss, R.A. Rosenheck, M.M. Desai, J.B. Perlin Quality of preventive medical care for patients with mental disorders Med Care 40 2 2002 129 136
12. O. Lord, D. Malone, A.J. Mitchell Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis Gen Hosp Psychiatry 32 5 2010 519 543
13. C.P. Carney, L.E. Jones The influence of type and severity of mental illness on receipt of screening mammography J Gen Intern Med 21 10 2006 1097 1104
14. J. Currie, J. Gruber Public health insurance and medical treatment: the equalizing impact of the Medicaid expansion J Public Econ 82 1 2001 63 69
15. S.M. Koroukian Screening mammography was used more, and more frequently, by longer than shorter term Medicaid enrollees J Clin Epidemiol 57 8 2004 824 831
16. B.R. Hirsch, G.H. Lyman Breast cancer screening with mammography Curr Oncol Rep 13 1 2011 63 70
17. A. Elixhauser, C. Steiner, D.R. Harris, R.M. Coffey Comorbidity measures for use with administrative data Med Care 36 1 1998 8 27
18. J. Swan, N. Breen, B.I. Graubard Data and trends in cancer screening in the U.S.: results from the 2005 National Health Interview Survey Cancer 116 20 2010 4872 4881